Kaplan–Meier analysis demonstrated that CD147-high gastric adenocarcinoma patients had significantly worse overall survival, faster disease progression, and reduced post-progression survival compared to CD147-low counterparts (all log-rank p < 0.001; Fig. 6L–N). This evidence concerns the gene BSG and gastric adenocarcinoma.